ABVC BioPharma Inc

NASDAQ:ABVC   10:42:18 AM EDT
0.75
0.00 (0.00%)
Earnings Announcements

ABVC BioPharma Reports Third Quarter 2022 Financial, Operational Results

Published: 11/14/2022 23:29 GMT
ABVC BioPharma Inc (ABVC) - Abvc Biopharma Reports Third Quarter 2022 Financial and Operational Results.
Abvc Biopharma Inc - Qtrly Loss per Share of $0.11.
Revenue is expected to be $0.03 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.